Noninvasive glucose detection system
By integrating an interstitial fluid extraction device and a photoelectric sensing module on a flexible substrate, and utilizing reverse ion electroosmosis and a Cu single-atom imprinted recognition layer, the low sampling efficiency and insufficient stability of existing non-invasive glucose detection methods are solved, achieving non-invasive, continuous, and accurate glucose detection, which is suitable for health monitoring of diabetic patients.
Patent Information
- Application Number
- CN202512051664.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-12-31
- Publication Date
- 2026-02-17
AI Technical Summary
Existing non-invasive glucose detection technologies suffer from low sampling efficiency, poor anti-interference ability, and insufficient stability, making it difficult to achieve continuous and accurate glucose detection.
The system employs an interstitial fluid extraction device and photoelectric sensing module integrated on a flexible substrate. It utilizes reverse ion electroosmosis technology to extract subcutaneous interstitial fluid, and specifically captures glucose molecules through a Cu single-atom imprinted recognition layer. The system then combines a titanium dioxide photosensitive semiconductor substrate for photoelectric signal conversion, and the main control circuit performs data processing and correction.
It enables non-invasive, continuous, and accurate glucose testing, reduces the risk of pain and infection, and improves the selectivity and stability of the test, making it suitable for home health monitoring for diabetic patients.